Liver Diseases Clinical Trials

ReadTheTrial indexes 1 studies for Liver Diseases. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Liver Diseases.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for Liver Diseases

A Phase 1/2, Open-Label, Single-Arm Study to Evaluate the Safety, Immunogenicity Reduction, Transplant Function, and Feasibility of Ex Vivo CRISPR-Cas9 Gene-Edited Donor Liver Transplantation Targeting HLA Class I (HLA-A, HLA-B) and Class II (Via CIITA) Genes.

NCT07053488 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Liver Diseases?

There are 1 clinical trials listed for Liver Diseases. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Liver Diseases trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Liver Diseases trials in?

Current Liver Diseases trials are distributed across: Phase 2 (1).

Find More Trials